[P25-7] P25-7: Immunosuppressive drugs (2): Monoclonal antibody and genotyping

[P25-7-6] TDM of infliximab by LC-MS/MS using nSMOL in patients with inflammatory bowel disease

Atsushi Yonezawa¹, Yasuaki Ikemi², Yuki Otani³, Syo Masui⁴, Satoshi Imai⁵, Shunsaku Nakagawa⁶, Noriko Iwamoto⁷, Takashi Shimada⁸, Minoru Matsuura⁹, Hiroshi Nakase¹⁰, Kazuo Matsubara¹¹ (1.Kyoto University Hospital, 2.Kyoto University Hospital, 3.Kyoto University Hospital, 4.Kyoto University Hospital, 5.Kyoto University Hospital, 6.Kyoto University Hospital, 7.SHIMADZU Corporation, 8.SHIMADZU Corporation, 9.Kyoto University, 10.Kyoto University, 11.Kyoto University Hospital)

キーワード：Infliximab, anti-drug antibody, LC-MS/MS, tumor necrosis factor alpha, inflammatory bowel disease